Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

74 API Suppliers, 34 USDMF, 29 CEP/COS, 9 JDMF, 8 EU WC, 7 KDMF, 28 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers, 39 FDA Orange Book, 131 Europe, 21 Canada, 59 Australia, 29 South Africa, 29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 1 Jai Radhe Sales, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 10 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Solubilizers, 21 Fillers, Diluents & Binders, 17 Direct Compression, 17 Thickeners and Stabilizers, 11 Parenteral, 10 Topical, 10 Coating Systems & Additives, 10 Co-Processed Excipients, 9 Film Formers & Plasticizers, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 5 Emulsifying Agents, 5 Controlled & Modified Release, 3 Lubricants & Glidants, 3 Taste Masking, 2 Coloring Agents, 2 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 110 Finished Drug Prices, 14 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/10/2024	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN	R1-CEP 2007-194 - Rev 03	Mometasone furoate, Micronised	2022-08-26	Valid	Chemical		1449
28/10/2024	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LIMITED New Delhi IN	CEP 2024-282 - Rev 00	Mometasone furoate monohydrate, Micronised	2024-10-17	Valid	Chemical		2858

Mometasone Furoate

Mometasone Furoate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

74 API Suppliers

34 USDMF

29 CEP/COS

9 JDMF

8 EU WC

7 KDMF

28 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers

39 FDA Orange Book

131 Europe

21 Canada

59 Australia

29 South Africa

29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.05MG/INH

AEROSOL, METERED;INHALATION - 0.10MG/INH

AEROSOL, METERED;INHALATION - 0.20MG/INH

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 0.11MG/INH

POWDER;INHALATION - 0.22MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

4 DKSH

1 Jai Radhe Sales

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

3 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

10 Kerry

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

9 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Solubilizers

21 Fillers, Diluents & Binders

17 Direct Compression

17 Thickeners and Stabilizers

11 Parenteral

10 Topical

10 Coating Systems & Additives

10 Co-Processed Excipients

9 Film Formers & Plasticizers

7 Granulation

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons